SpiroGen's Acquisition

SpiroGen was acquired by MedImmune on October 15, 2013.

The Spirogen group was founded in 2001 as a spin-out from several institutions including University College, London and partly funded by Cancer Research UK.The group has developed a novel class of hig…

Articles about SpiroGen's Acquisition: